Importance: The choice between chemotherapy and endocrine therapy as first-line treatment for hormone receptor-positive, ERBB2 (also known as HER2)-negative metastatic breast cancer is usually based on the presence of clinical features associated with a poor prognosis. In this setting, a high circulating tumor cell (CTC) count (≥5 CTCs/7.5 mL)...
-
January 1, 2021 (v1)Journal articleUploaded on: December 3, 2022
-
February 2022 (v1)Journal article
Objective: To determine the value of performing a risk-reducting mastectomy (RRM) in the absence of a deleterious variant of a breast cancer susceptibility gene, in 4 clinical situations at risk of breast cancer.Design: The CNGOF Commission of Senology, composed of 26 experts, developed these recommendations. A policy of declaration and...
Uploaded on: November 25, 2023